Data / Form D filings / Cerium Pharmaceuticals, Inc.
Cerium Pharmaceuticals, Inc.: Form D filings
Cerium Pharmaceuticals, Inc., a pharmaceuticals company in Gaithersburg, MD, filed 4 Form D notices with the SEC between 2016 and 2026. The latest, on August 6, 2026, reports $750,000 sold of a $2.5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 312 MAIN STREET SUITE 300, Gaithersburg, MD, 20878
- Phone
- (703) 229-2508
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1677995
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | New notice | $2,544,000 | $750,000 | $1,794,000 | 4 | May 22, 2026 | sec.gov |
| Jul 30, 2021 | New notice | $10,052,959 | $8,900,000 | $1,152,959 | 5 | Jul 22, 2021 | sec.gov |
| May 25, 2021 | New notice | $1,905,432 | $1,905,432 | 9 | Mar 26, 2021 | sec.gov | |
| Jun 27, 2016 | New notice | $7,273,674 | $2,273,681 | $4,999,993 | 9 | Jun 13, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregg A. Lapointe | Executive Officer, Director | |
| Peter Collum | Director | |
| Steve Eskenazi | Director | |
| Robert Rubin | Director | |
| Tom DePasquale | Director | |
| James Gale | Director |
Every Form D from the week of Aug 3, 2026 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cerium Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.